Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Delcath Systems, Inc.

Delcath Systems to Host Third Quarter 2025 Earnings Call
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems to Participate in Upcoming Investor Conferences
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Reports Second Quarter 2025 Results and Business Highlights
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth Conference
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems to Host Second Quarter 2025 Earnings Call
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Issues Full Year 2025 Guidance
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Reports First Quarter 2025 Results and Business Highlights
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems to Host First Quarter 2025 Earnings Call
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Reports Fourth Quarter and Full Year 2024 Results
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems Reports Third Quarter 2024 Results and Business Highlights
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Delcath Systems to Participate in Upcoming Investor Conferences
From Delcath Systems, Inc.
Via Business Wire
Tickers DCTH
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.